Ameritas Investment Partners, Inc. Charles River Laboratories International, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q3 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 5,045 shares of CRL stock, worth $947,955. This represents 0.03% of its overall portfolio holdings.
Number of Shares
5,045
Previous 5,045
-0.0%
Holding current value
$947,955
Previous $1.04 Million
4.7%
% of portfolio
0.03%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding CRL
# of Institutions
696Shares Held
52.3MCall Options Held
259KPut Options Held
463K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.15 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$956 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.74MShares$703 Million0.13% of portfolio
-
State Street Corp Boston, MA2.13MShares$400 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.94MShares$364 Million0.87% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.56B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...